Tag Cloud Results

Results found matching tag Lonza

From the News
Lonza to Adpapt its Management Structure to Focus on Target Markets and Improve Profitability
Lonza Joins Roundtable on Sustainable Palm Oil
Lonza to Expand Antibody Drug Conjugate (ADC) Manufacturing Capacity to Meet Growing Customer Demand
Lonza Signs Definitive Agreement for the Sale of Brandenburg, KY, Performance Urethanes and Organics ...
Agreements of the Negotiations Between Unia, Syna and Lonza
Lonza Delivers Solid Performance in Q3; Cost Improvement Programs on Track
Lonza Awarded Contract to Generate Clinical Grade iPSCs by the National Institutes of Health Center for ...
Lonza and Celladon Corporation Announce Manufacturing Agreement for MYDICAR®
Lonza Announces License Agreement with iPS Academia Japan
Lonza Delivered Solid Business Performance in the First Half of 2012
Lonza Launches Next Generation GS Gene Expression System™
Oxford BioTherapeutics licenses Lonza's GS Gene Expression System
Lonza celebrates 40 years as leading producer of vitamin B3
Lonza, JFC Technologies and Novoset LLC announce a strategic collaboration to advance high performance ...
Lonza to appoint Jeanne Thoma as future COO of the Microbial Control sector
Lonza extends tender offer for all outstanding shares of Arch Chemicals common stock to 12 September ...
Lonza to invest in long-term growing Meta metaldehyde business
Lonza and Cellectis bioresearch achieve significant milestone on CHO-K1SV GS knock-out
Lonza signs manufacturing deal with IMMUNE Pharmaceuticals for Bertilimumab
Lonza to acquire Arch Chemicals to create the world’s leading Microbial Control business
Lonza's New GS System Medium and Feed Plat5form Reaches 10g/L
Lonza Introduces Light Path: Streamlined Process Development and Custom Material Supply for Discovery ...
Lonza to expand in Singapore to meet increasing demand for biopharma
Lonza to expand viral production capacity
Lonza to Expand Cytotoxic Manufacturing to Serve Growing Oncology API Market
Lonza and ORGANOBALANCE Enter Global License Agreement to Develop and Market Unique Probiotic (Lactobacillus ...
Lonza and Roche enter into MycoTOOL distribution agreement for rapid mycoplasma testing solutions
Lonza to invest £16 million to expand its Slough facility
Lonza Signs Development and Manufacturing Agreement with Emerging Biotech Company Athera
Lonza Signs Commercial Manufacturing Deal with Enobia for Orphan Drug Candidate
Lonza delivered a robust operating performance in 2010
Lonza announces organizational changes in Media Relations
Lonza selects IDBS to optimize bioprocess execution & knowledge management
Lonza announces new head of Lonza Life Science ingredients